After analyzing millions of Internet visits and interviewing scores of consumers, Brookdale Senior Living has built a new website based on fresh insights into what’s most important to families searching for senior care. The first phase, which is a $4 million investment, went live on brookdale.com mid-August.
“With Brookdale’s website attracting more than 500,000 visits every month, it’s imperative to make it as useful to consumers as possible,” said David Cygan, Brookdale’s senior vice president of marketing. “As the nation’s largest senior living provider, we know our website is a primary source of information, with many people coming to us first as they embark on this journey,” Cygan said. “It’s important that we offer substantive resources that make it easier to find help in evaluating senior care options.” More than 80 percent of adult children turn to the Internet when they look for care for an aging parent, according to the company’s research.
To view the multimedia release go to:
http://www.multivu.com/players/English/7722159-new-brookdale-senior-living-website/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Typical bathroom products like shampoo bottles, toilet paper rolls and toothpaste boxes are significantly less likely to be recycled than kitchen products according to survey results released today by the Ad Council. Nonprofits Keep America Beautiful and the Ad Council have joined with Unilever to expand the conversation around recycling and motivate more Americans to remember to recycle in the bathroom by launching a new phase of the national, award-winning “I Want To Be Recycled” communications campaign, featuring a brand new series of broadcast and digital PSAs.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7444951-keep-america-beautiful-recycle/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
ITC Transmission, a wholly-owned subsidiary of ITC Holdings Corp., the nation’s largest independent electricity transmission company, today announced its Thumb Loop high-voltage transmission project is complete with the energization of the third and final phase of the project. ITC invested an estimated $510 million to build the 345,000 volt (345 kV) line, which serves as the backbone of a system designed to meet the identified maximum wind energy potential of Michigan’s Thumb region. It also will contribute to regional system reliability and facilitate wholesale market competition.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7523851-itctransmission-thumb-loop/
Kubota Tractor Corporation has announced the availability of its second phase of all-new Kubota Hay Tools in dealerships nationwide. The recently expanded hay tools line brings to market new round balers and turntable bale wrappers; side-mounted and trailed disc mowers; trailed mower conditioners; and a complete range of rotary tedders and rakes.
The new machinery is designed specifically for the U.S. market to further expand Kubota's presence in the larger agricultural product market. "With our extended line of hay tools, we are building on the success of our well-received initial hay tools launch last year and responding to outstanding dealer and customer demand for more high-performing implements from Kubota," said Dave Palmer, senior product manager of Kubota hay tools. "Kubota understands that our customers depend on our equipment's productivity and by providing the right tools, we always deliver. Kubota's hay tools are performance-matched to ideally complement our M-Series tractors and deliver a more comprehensive line of haying solutions for our customers' needs."
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7443251-kubota-tractor-hay-tools/
The winners of the Natural Light - International Design Competition have now been chosen from the 172 impressive Natural Light Lamp designs submitted from 65 countries around the world. The winners are two very talented Argentinian Industrial Design students, Ms. Mariana Arando and Mr. Luca Fondello, both from the University of Buenos Aires, Argentina. The production phase of the winning design for the Natural Light Lamp will begin shortly, followed next year by shipment of the lamps to three African countries without access to electricity.
Last year, the VELUX Group and Little Sun joined forces to launch the Natural Light – International Design Competition, which challenged design students around the world to create a design for a solar lamp which would help to bring clean, reliable, affordable light to some of the 1.2 billion people worldwide living without electricity. Now the jury has voted and decided on the winning solar lamp design by two Industrial Design students from the University of Buenos Aires in Argentina.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7533451-velux-winner-announcement-natural-light/
Volkswagen startet 30 Jahre nach seinem Markteintritt in China in eine Phase nachhaltigen Wachstums. Im Zuge des Ausbaus der Fertigungskapazitäten investieren die beiden chinesischen Joint-Ventures des Volkswagen Konzerns bis 2015 mehr als zwei Drittel von insgesamt 9,8 Milliarden Euro in hocheffiziente Produkte. Der für China zuständige Vorstand der Volkswagen Aktiengesellschaft Prof. Dr. Jochem Heizmann, präzisierte am Vortag der Auto Shanghai 2013 die auf den chinesischen Markt zugeschnittene Elektromobilitäts-Strategie. Es sei geplant, von 2014/2015 an Fahrzeuge mit elektrifiziertem Antrieb anzubieten, die zum Teil lokal produziert werden. Bereits 26 Modelle des Konzerns sind von staatlicher Seite als besonders energiesparend und umweltschonend anerkannt worden. Volkswagen habe den verbrauch seiner in China derzeit mehr als 70 Modelle umfassenden Flotte zwischen 2005 und 2010 um 20 Prozent reduziert und werde ihn bis 2015 um weitere 11 Prozent senken.
XCMG, the world’s fifth largest construction equipment company, unveils the XE15R hydraulic intelligent excavator, its first fully remote-controlled excavator, signaling a new phase in XCMG’s intelligentization of its excavator series.
Without a cab, XE15R is the company’s smallest excavator at 1.35m in height and 1.08m in width. Nicknamed “Little Swan”, the machine is agile and flexible in challenging working conditions.
The newly developed XE15R features a wireless control function with a 100-meter range, and integrates mechanic, electronic and hydraulic control technology with a CAN bus interface design. Unmanned driving reduces labor intensity, particularly useful in severe operating environments, such as toxic conditions or extreme temperatures.
As an intelligent excavator, XE15R also features a self-learning function. It can save operating maneuvers and then replay them automatically on request, a breakthrough that further ensures security, agility and reliability in operation.
“Intelligentization is an inevitable choice as XCMG follows the path of new industrialization, and XE15R shows that we do what we say. Its design embodies our pursuit of efficiency and user friendliness.” said Wang Min, president of XCMG. The launching of XE15R expands XCMG’s product line, and improves its customers’ construction quality, providing them with a more human-friendly working environment and better project solutions.
To view the multimedia release please visit
http://www.multivu.com/players/English/7605551-xcmg-xe15r-remote-controlled-excavator/
The sixth annual Productive Innovation Index released by IDEA Pharma today, which ranks biopharmaceutical companies by their ability to successfully bring innovations to market, sees Johnson & Johnson top the industry for the fourth year running.
The Productive Innovation Index measures, scores and celebrates a company’s ability to deliver innovation to patients, by objectively evaluating performance data based on a rolling five year period (2010-2015), and operates on the premise: if you gave the same molecule to two different companies in early phase, which would make the best of it?
The success of the Janssen Pharmaceutical Companies of Johnson & Johnson and its consolidation of 1st place across the past four years’ rankings is driven largely by innovations in the field of oncology, immunology, neuroscience and cardiovascular/metabolism. Notable performers include Zytiga® (prostate cancer), Imbruvica® (chronic lymphocytic leukemia and mantle cell lymphoma (co-developed and co-marketed with Pharmacyclics, an AbbVie company)), Simponi®/Simponi Aria® (rheumatoid arthritis), Stelara® (psoriasis and psoriatic arthritis), Invega Sustenna® and Invega Trinza® (schizophrenia).
To view the multimedia release go to:
http://www.multivu.com/players/uk/7770851-johnson-and-johnson-tops-idea-pharma/
Zensun Sci & Tech, Ltd., a biopharmaceutical company based in Shanghai and San Diego, announced today positive results of four completed Phase 2 clinical trials including three double-blind, placebo-controlled studies conducted in China and Australia and interim results from the United States Phase 2 trial for Zensun’s innovative “first-in-class” anti-heart failure drug, Neucardin™.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61677-zensun-completes-clinical-trials-of-neucardin-treatment-of-heart-failure
Live Looping with an RC- 300, GR-20, Digitech Jamman, phase shifter, ambient reverb, tera echo, and a Boss Digital Delay. The RC - 300 is used to loop guitar all on separate loops/tracks, the pedals are used to create ambient and delayed sounds with the guitar.
Video by HouseTwelve Media (http://www.housetwelve.com/)
